G Norbert Riedel

Affiliations

  • Director at Eton Pharmaceuticals Inc. (ETON), 2025-01-06
  • Director at Jazz Pharmaceuticals Plc (JAZZ), 2024-08-06
  • at Cerevel Therapeutics Holdings Inc. (CERE), 2024-08-05
  • Executive Chairman Of The Bod at Aptinyx Inc. (APTX), 2023-01-05
  • Director at Ariad Pharmaceuticals Inc (ARIA), 2017-02-16
  • Corporate Vice President at Baxter International Inc (BAX), 2013-01-18
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
APTX $2.23 100,000 $223,000.00 100,000 2021-12-06 Filing
APTX $3.00 35,000 $105,000.00 35,000 2020-01-10 Filing
ETON $6.00 5,000 $30,000.00 59,745 2018-11-15 Filing
APTX $16.00 2,400 $38,400.00 5,118 2018-06-25 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
JAZZ $138.16 1,241 $171,454.20 13,705 2023-08-14 Filing
JAZZ $152.32 1,089 $165,876.92 11,871 2022-08-08 Filing
JAZZ $155.87 8,000 $1,246,920.00 10,399 2022-08-05 Filing
JAZZ $147.96 1,306 $193,235.76 10,399 2021-08-06 Filing
JAZZ $125.87 931 $117,185.71 9,459 2020-08-07 Filing